-
1
-
-
78149484622
-
In vivo deficiency of both C/EBPbeta and C/EBPepsilon results in highly defective myeloid differentiation and lack of cytokine response
-
Akagi, T., Thoennissen, N. H., George, A., Crooks, G. et al., In vivo deficiency of both C/EBPbeta and C/EBPepsilon results in highly defective myeloid differentiation and lack of cytokine response. PloS One 2010, 5, e15419.
-
(2010)
PloS One
, vol.5
-
-
Akagi, T.1
Thoennissen, N.H.2
George, A.3
Crooks, G.4
-
2
-
-
84864223775
-
Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma
-
Thoennissen, N. H., Thoennissen, G. B., Abbassi, S., Nabavi-Nouis, S. et al., Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma. Leuk. Lymphoma 2012, 53, 1577-1585.
-
(2012)
Leuk. Lymphoma
, vol.53
, pp. 1577-1585
-
-
Thoennissen, N.H.1
Thoennissen, G.B.2
Abbassi, S.3
Nabavi-Nouis, S.4
-
3
-
-
84865963692
-
C/EBPepsilon mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice
-
Kyme, P., Thoennissen, N. H., Tseng, C. W., Thoennissen, G. B. et al., C/EBPepsilon mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice. J. Clin. Invest. 2012, 122, 3316-3329.
-
(2012)
J. Clin. Invest.
, vol.122
, pp. 3316-3329
-
-
Kyme, P.1
Thoennissen, N.H.2
Tseng, C.W.3
Thoennissen, G.B.4
-
4
-
-
27644566447
-
Biologic therapy for inflammatory bowel disease
-
Ardizzone, S., Bianchi Porro, G., Biologic therapy for inflammatory bowel disease. Drugs 2005, 65, 2253-2286.
-
(2005)
Drugs
, vol.65
, pp. 2253-2286
-
-
Ardizzone, S.1
Bianchi Porro, G.2
-
5
-
-
34547176642
-
Unravelling the pathogenesis of inflammatory bowel disease
-
Xavier, R. J., Podolsky, D. K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448, 427-434.
-
(2007)
Nature
, vol.448
, pp. 427-434
-
-
Xavier, R.J.1
Podolsky, D.K.2
-
6
-
-
35348982262
-
Mouse models of inflammatory bowel disease
-
Wirtz, S., Neurath, M. F., Mouse models of inflammatory bowel disease. Adv. Drug. Deliv. Rev. 2007, 59, 1073-1083.
-
(2007)
Adv. Drug. Deliv. Rev.
, vol.59
, pp. 1073-1083
-
-
Wirtz, S.1
Neurath, M.F.2
-
7
-
-
84860241737
-
Innate immune dysfunction in inflammatory bowel disease
-
Gersemann, M., Wehkamp, J., Stange, E. F., Innate immune dysfunction in inflammatory bowel disease. J. Intern. Med. 2012, 271, 421-428.
-
(2012)
J. Intern. Med.
, vol.271
, pp. 421-428
-
-
Gersemann, M.1
Wehkamp, J.2
Stange, E.F.3
-
8
-
-
0037048904
-
Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor
-
Dieckgraefe, B. K., Korzenik, J. R., Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 2002, 360, 1478-1480.
-
(2002)
Lancet
, vol.360
, pp. 1478-1480
-
-
Dieckgraefe, B.K.1
Korzenik, J.R.2
-
9
-
-
84864270714
-
ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation
-
Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J. et al., ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012, 487, 477-481.
-
(2012)
Nature
, vol.487
, pp. 477-481
-
-
Hashimoto, T.1
Perlot, T.2
Rehman, A.3
Trichereau, J.4
-
10
-
-
34247158656
-
PARP inhibition reduces acute colonic inflammation in rats
-
Sanchez-Fidalgo, S., Villegas, I., Martin, A., Sanchez-Hidalgo, M., Alarcon de la Lastra, C., PARP inhibition reduces acute colonic inflammation in rats. Eur. J. Pharmacol. 2007, 563, 216-223.
-
(2007)
Eur. J. Pharmacol.
, vol.563
, pp. 216-223
-
-
Sanchez-Fidalgo, S.1
Villegas, I.2
Martin, A.3
Sanchez-Hidalgo, M.4
Alarcon de la Lastra, C.5
-
11
-
-
0032726370
-
Citrobacter rodentium espB is necessary for signal transduction and for infection of laboratory mice
-
Newman, J. V., Zabel, B. A., Jha, S. S., Schauer, D. B., Citrobacter rodentium espB is necessary for signal transduction and for infection of laboratory mice. Infect. Immun. 1999, 67, 6019-6025.
-
(1999)
Infect. Immun.
, vol.67
, pp. 6019-6025
-
-
Newman, J.V.1
Zabel, B.A.2
Jha, S.S.3
Schauer, D.B.4
-
12
-
-
0027254194
-
Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy
-
Horsman, M. R., Hoyer, M., Honess, D. J., Dennis, I. F., Overgaard, J., Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy. Radiother. Oncol. 1993, 27, 131-139.
-
(1993)
Radiother. Oncol.
, vol.27
, pp. 131-139
-
-
Horsman, M.R.1
Hoyer, M.2
Honess, D.J.3
Dennis, I.F.4
Overgaard, J.5
-
13
-
-
33748908067
-
Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models
-
Kaneko, S., Wang, J., Kaneko, M., Yiu, G. et al., Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J. Neurosci. 2006, 26, 9794-9804.
-
(2006)
J. Neurosci.
, vol.26
, pp. 9794-9804
-
-
Kaneko, S.1
Wang, J.2
Kaneko, M.3
Yiu, G.4
-
14
-
-
80052864077
-
The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function
-
Bettenworth, D., Buyse, M., Bohm, M., Mennigen, R. et al., The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function. Am. J. Pathol. 2011, 179, 1230-1242.
-
(2011)
Am. J. Pathol.
, vol.179
, pp. 1230-1242
-
-
Bettenworth, D.1
Buyse, M.2
Bohm, M.3
Mennigen, R.4
-
15
-
-
0036839239
-
Neutrophils play a critical role in development of LPS-induced airway disease
-
Savov, J. D., Gavett, S. H., Brass, D. M., Costa, D. L., Schwartz, D. A., Neutrophils play a critical role in development of LPS-induced airway disease. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 283, L952-L962.
-
(2002)
Am. J. Physiol. Lung Cell Mol. Physiol.
, vol.283
-
-
Savov, J.D.1
Gavett, S.H.2
Brass, D.M.3
Costa, D.L.4
Schwartz, D.A.5
-
16
-
-
21244434677
-
Inactivation of CD11b in a mouse transgenic model protects against sepsis-induced lung PMN infiltration and vascular injury
-
Gao, X. P., Liu, Q., Broman, M., Predescu, D. et al., Inactivation of CD11b in a mouse transgenic model protects against sepsis-induced lung PMN infiltration and vascular injury. Physiol. Genom. 2005, 21, 230-242.
-
(2005)
Physiol. Genom.
, vol.21
, pp. 230-242
-
-
Gao, X.P.1
Liu, Q.2
Broman, M.3
Predescu, D.4
-
17
-
-
7644235586
-
The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis
-
Spahn, T. W., Maaser, C., Eckmann, L., Heidemann, J. et al., The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis. Gastroenterology 2004, 127, 1463-1473.
-
(2004)
Gastroenterology
, vol.127
, pp. 1463-1473
-
-
Spahn, T.W.1
Maaser, C.2
Eckmann, L.3
Heidemann, J.4
-
18
-
-
38849178169
-
CD4+ T cells transfer resistance against Citrobacter rodentium-induced infectious colitis by induction of Th 1 immunity
-
Spahn, T. W., Ross, M., von Eiff, C., Maaser, C. et al., CD4+ T cells transfer resistance against Citrobacter rodentium-induced infectious colitis by induction of Th 1 immunity. Scand. J. Immunol. 2008, 67, 238-244.
-
(2008)
Scand. J. Immunol.
, vol.67
, pp. 238-244
-
-
Spahn, T.W.1
Ross, M.2
von Eiff, C.3
Maaser, C.4
-
19
-
-
0031736096
-
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines
-
Dieleman, L. A., Palmen, M. J., Akol, H., Bloemena, E. et al., Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 1998, 114, 385-391.
-
(1998)
Clin. Exp. Immunol.
, vol.114
, pp. 385-391
-
-
Dieleman, L.A.1
Palmen, M.J.2
Akol, H.3
Bloemena, E.4
-
20
-
-
22944462082
-
Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity
-
Liu, G. Y., Essex, A., Buchanan, J. T., Datta, V. et al., Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 2005, 202, 209-215.
-
(2005)
J. Exp. Med.
, vol.202
, pp. 209-215
-
-
Liu, G.Y.1
Essex, A.2
Buchanan, J.T.3
Datta, V.4
-
21
-
-
33749011189
-
Animal models of inflammatory bowel disease: lessons from enteric infections
-
Eckmann, L., Animal models of inflammatory bowel disease: lessons from enteric infections. Ann. N. Y. Acad. Sci. 2006, 1072, 28-38.
-
(2006)
Ann. N. Y. Acad. Sci.
, vol.1072
, pp. 28-38
-
-
Eckmann, L.1
-
22
-
-
0347364688
-
Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen
-
Bry, L., Brenner, M. B., Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J. Immunol. 2004, 172, 433-441.
-
(2004)
J. Immunol.
, vol.172
, pp. 433-441
-
-
Bry, L.1
Brenner, M.B.2
-
23
-
-
84887609133
-
Serum calprotectin as a biomarker for Crohn's disease
-
Meuwis, M. A., Vernier-Massouille, G., Grimaud, J. C., Bouhnik, Y. et al., Serum calprotectin as a biomarker for Crohn's disease. J. Crohn's Colitis 2013, 7, e678-e683.
-
(2013)
J. Crohn's Colitis
, vol.7
-
-
Meuwis, M.A.1
Vernier-Massouille, G.2
Grimaud, J.C.3
Bouhnik, Y.4
-
24
-
-
18544381583
-
CCAAT/enhancer binding protein epsilon: changes in function upon phosphorylation by p38 MAP kinase
-
Williamson, E. A., Williamson, I. K., Chumakov, A. M., Friedman, A. D., Koeffler, H. P., CCAAT/enhancer binding protein epsilon: changes in function upon phosphorylation by p38 MAP kinase. Blood 2005, 105, 3841-3847.
-
(2005)
Blood
, vol.105
, pp. 3841-3847
-
-
Williamson, E.A.1
Williamson, I.K.2
Chumakov, A.M.3
Friedman, A.D.4
Koeffler, H.P.5
-
25
-
-
28044461045
-
Citrobacter rodentium of mice and man
-
Mundy, R., MacDonald, T. T., Dougan, G., Frankel, G., Wiles, S., Citrobacter rodentium of mice and man. Cell Microbiol. 2005, 7, 1697-1706.
-
(2005)
Cell Microbiol.
, vol.7
, pp. 1697-1706
-
-
Mundy, R.1
MacDonald, T.T.2
Dougan, G.3
Frankel, G.4
Wiles, S.5
-
26
-
-
34447269492
-
Development of fatal colitis in FVB mice infected with Citrobacter rodentium
-
Borenshtein, D., Nambiar, P. R., Groff, E. B., Fox, J. G., Schauer, D. B., Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect. Immun. 2007, 75, 3271-3281.
-
(2007)
Infect. Immun.
, vol.75
, pp. 3271-3281
-
-
Borenshtein, D.1
Nambiar, P.R.2
Groff, E.B.3
Fox, J.G.4
Schauer, D.B.5
-
27
-
-
0038443912
-
Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium
-
Vallance, B. A., Deng, W., Jacobson, K., Finlay, B. B., Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect. Immun. 2003, 71, 3443-3453.
-
(2003)
Infect. Immun.
, vol.71
, pp. 3443-3453
-
-
Vallance, B.A.1
Deng, W.2
Jacobson, K.3
Finlay, B.B.4
-
28
-
-
33748449456
-
Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map)
-
Ma, C., Wickham, M. E., Guttman, J. A., Deng, W. et al., Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell Microbiol. 2006, 8, 1669-1686.
-
(2006)
Cell Microbiol.
, vol.8
, pp. 1669-1686
-
-
Ma, C.1
Wickham, M.E.2
Guttman, J.A.3
Deng, W.4
-
29
-
-
0033022537
-
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease
-
Higgins, L. M., Frankel, G., Douce, G., Dougan, G., MacDonald, T. T., Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun. 1999, 67, 3031-3039.
-
(1999)
Infect. Immun.
, vol.67
, pp. 3031-3039
-
-
Higgins, L.M.1
Frankel, G.2
Douce, G.3
Dougan, G.4
MacDonald, T.T.5
-
30
-
-
80051826190
-
Interactions with M cells and macrophages as key steps in the pathogenesis of enterohemorrhagic Escherichia coli infections
-
Etienne-Mesmin, L., Chassaing, B., Sauvanet, P., Denizot, J. et al., Interactions with M cells and macrophages as key steps in the pathogenesis of enterohemorrhagic Escherichia coli infections. PLoS One 2011, 6, e23594.
-
(2011)
PLoS One
, vol.6
-
-
Etienne-Mesmin, L.1
Chassaing, B.2
Sauvanet, P.3
Denizot, J.4
-
31
-
-
78649988873
-
Tumor necrosis factor blockade for treatment of inflammatory bowel disease: efficacy and safety
-
Ngo, B., Farrell, C. P., Barr, M., Wolov, K. et al., Tumor necrosis factor blockade for treatment of inflammatory bowel disease: efficacy and safety. Curr. Mol. Pharmacol. 2010, 3, 145-152.
-
(2010)
Curr. Mol. Pharmacol.
, vol.3
, pp. 145-152
-
-
Ngo, B.1
Farrell, C.P.2
Barr, M.3
Wolov, K.4
-
32
-
-
84862286661
-
Immunosuppression in inflammatory bowel disease: how much is too much
-
Cohen, B. L., Torres, J., Colombel, J. F., Immunosuppression in inflammatory bowel disease: how much is too much? Curr. Opin. Gastroenterol. 2012, 28, 341-348.
-
(2012)
Curr. Opin. Gastroenterol.
, vol.28
, pp. 341-348
-
-
Cohen, B.L.1
Torres, J.2
Colombel, J.F.3
-
33
-
-
84858793037
-
Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms
-
Ordas, I., Mould, D. R., Feagan, B. G., Sandborn, W. J., Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Clin. Pharmacol. Ther. 2012, 91, 635-646.
-
(2012)
Clin. Pharmacol. Ther.
, vol.91
, pp. 635-646
-
-
Ordas, I.1
Mould, D.R.2
Feagan, B.G.3
Sandborn, W.J.4
-
34
-
-
46349102893
-
Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease
-
Simms, L. A., Doecke, J. D., Walsh, M. D., Huang, N. et al., Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008, 57, 903-910.
-
(2008)
Gut
, vol.57
, pp. 903-910
-
-
Simms, L.A.1
Doecke, J.D.2
Walsh, M.D.3
Huang, N.4
-
35
-
-
78751653584
-
Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1
-
Schroeder, B. O., Wu, Z., Nuding, S., Groscurth, S. et al., Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 2011, 469, 419-423.
-
(2011)
Nature
, vol.469
, pp. 419-423
-
-
Schroeder, B.O.1
Wu, Z.2
Nuding, S.3
Groscurth, S.4
-
36
-
-
34347262689
-
Chemically induced mouse models of intestinal inflammation
-
Wirtz, S., Neufert, C., Weigmann, B., Neurath, M. F., Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2007, 2, 541-546.
-
(2007)
Nat. Protoc.
, vol.2
, pp. 541-546
-
-
Wirtz, S.1
Neufert, C.2
Weigmann, B.3
Neurath, M.F.4
-
37
-
-
84866914800
-
Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction
-
Dicksved, J., Schreiber, O., Willing, B., Petersson, J. et al., Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction. PLoS One 2012, 7, e46399.
-
(2012)
PLoS One
, vol.7
-
-
Dicksved, J.1
Schreiber, O.2
Willing, B.3
Petersson, J.4
-
38
-
-
79251581856
-
Importance and regulation of the colonic mucus barrier in a mouse model of colitis
-
Petersson, J., Schreiber, O., Hansson, G. C., Gendler, S. J. et al., Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300, G327-G333.
-
(2011)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.300
-
-
Petersson, J.1
Schreiber, O.2
Hansson, G.C.3
Gendler, S.J.4
-
39
-
-
79955555545
-
The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease
-
Lewis, J. D., The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011, 140, 1817-1826 e1812.
-
(2011)
Gastroenterology
, vol.140
-
-
Lewis, J.D.1
-
40
-
-
17044404692
-
Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens
-
Iimura, M., Gallo, R. L., Hase, K., Miyamoto, Y. et al., Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 2005, 174, 4901-4907.
-
(2005)
J. Immunol.
, vol.174
, pp. 4901-4907
-
-
Iimura, M.1
Gallo, R.L.2
Hase, K.3
Miyamoto, Y.4
-
41
-
-
36549048075
-
Utility of the Citrobacter rodentium infection model in laboratory mice
-
Borenshtein, D., McBee, M. E., Schauer, D. B., Utility of the Citrobacter rodentium infection model in laboratory mice. Curr. Opin. Gastroenterol. 2008, 24, 32-37.
-
(2008)
Curr. Opin. Gastroenterol.
, vol.24
, pp. 32-37
-
-
Borenshtein, D.1
McBee, M.E.2
Schauer, D.B.3
-
42
-
-
34250814435
-
TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium
-
Lebeis, S. L., Bommarius, B., Parkos, C. A., Sherman, M. A., Kalman, D., TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J. Immunol. 2007, 179, 566- 577.
-
(2007)
J. Immunol.
, vol.179
, pp. 566-577
-
-
Lebeis, S.L.1
Bommarius, B.2
Parkos, C.A.3
Sherman, M.A.4
Kalman, D.5
-
43
-
-
77950251400
-
A human gut microbial gene catalogue established by metagenomic sequencing
-
Qin, J., Li, R., Raes, J., Arumugam, M. et al., A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59-65.
-
(2010)
Nature
, vol.464
, pp. 59-65
-
-
Qin, J.1
Li, R.2
Raes, J.3
Arumugam, M.4
-
44
-
-
84889681706
-
Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation
-
Martinez-Medina, M., Denizot, J., Dreux, N., Robin, F. et al., Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 2014, 63, 116-124.
-
(2014)
Gut
, vol.63
, pp. 116-124
-
-
Martinez-Medina, M.1
Denizot, J.2
Dreux, N.3
Robin, F.4
-
45
-
-
34047252362
-
Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro
-
Meconi, S., Vercellone, A., Levillain, F., Payre, B. et al., Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro. Cellular Microbiol. 2007, 9, 1252-1261.
-
(2007)
Cellular Microbiol.
, vol.9
, pp. 1252-1261
-
-
Meconi, S.1
Vercellone, A.2
Levillain, F.3
Payre, B.4
-
46
-
-
0014817520
-
An evaluation of niacinamide in the treatment of childhood schizophrenia
-
Greenbaum, G. H., An evaluation of niacinamide in the treatment of childhood schizophrenia. Am. J. Psychiatry 1970, 127, 89-92.
-
(1970)
Am. J. Psychiatry
, vol.127
, pp. 89-92
-
-
Greenbaum, G.H.1
-
47
-
-
0015181325
-
Megavitamin B-3 therapy for schizophrenia
-
Hoffer, A., Megavitamin B-3 therapy for schizophrenia. Can. Psychiatr. Assoc. J. 1971, 16, 499-504.
-
(1971)
Can. Psychiatr. Assoc. J.
, vol.16
, pp. 499-504
-
-
Hoffer, A.1
-
48
-
-
0023929394
-
High dose nicotinamide in the treatment of necrobiosis lipoidica
-
Handfield-Jones, S., Jones, S., Peachey, R., High dose nicotinamide in the treatment of necrobiosis lipoidica. Br. J. Dermatol. 1988, 118, 693-696.
-
(1988)
Br. J. Dermatol.
, vol.118
, pp. 693-696
-
-
Handfield-Jones, S.1
Jones, S.2
Peachey, R.3
-
49
-
-
0348015990
-
Studies of nicotinic acid use in hypercholesteremia. Changes in hepatic function, carbohydrate tolerance, and uric acid metabolism
-
Parsons, W. B., Jr., Studies of nicotinic acid use in hypercholesteremia. Changes in hepatic function, carbohydrate tolerance, and uric acid metabolism. Arch. Intern. Med. 1961, 107, 653-667.
-
(1961)
Arch. Intern. Med.
, vol.107
, pp. 653-667
-
-
Parsons Jr., W.B.1
-
50
-
-
0033752240
-
Safety of high-dose nicotinamide: a review
-
Knip, M., Douek, I. F., Moore, W. P., Gillmor, H. A. et al., Safety of high-dose nicotinamide: a review. Diabetologia 2000, 43, 1337-1345.
-
(2000)
Diabetologia
, vol.43
, pp. 1337-1345
-
-
Knip, M.1
Douek, I.F.2
Moore, W.P.3
Gillmor, H.A.4
-
51
-
-
0031665078
-
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer
-
Bernier, J., Stratford, M. R., Denekamp, J., Dennis, M. F. et al., Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer. Radiother. Oncol. 1998, 48, 123-133.
-
(1998)
Radiother. Oncol.
, vol.48
, pp. 123-133
-
-
Bernier, J.1
Stratford, M.R.2
Denekamp, J.3
Dennis, M.F.4
-
52
-
-
84903553062
-
-
Subcommittee on Vitamin Tolerance, C. o. A. N., National Academies Press, Washington, DC .
-
Subcommittee on Vitamin Tolerance, C. o. A. N., Board on Agriculture and National Research Council, Vitamin Tolerance of Animals, National Academies Press, Washington, DC 1987.
-
(1987)
Board on Agriculture and National Research Council, Vitamin Tolerance of Animals
-
-
|